Vemurafenib, PLX4720, AZD6244 and U0126 were from Selleck Chemicals (Houston, TX). EGF, HB-EGF and p-RTK arrays were purchased from R&D (Minneapolis, MN). Doxycycline was from Clontech (Mountain View, CA). Antibodies against p-EGFR, EGFR, BRAF, p-MEK. MEK, p-ERK, ERK, p-AKT, AKT, GAPDH and α-tubulin were from Cell Signaling (Danvers, MA). CellTiter-Glo cell viability assay was from Promega (Madison, WI). AlamarBlue cell viability reagent was from Life Technologies (Grand Island, NY). Human phospho-RTK array kit was from R&D systems (Minneapolis, MN). siRNA against MITF and non-targeting control siRNA were from GE Dharmacon (Lafayette, CO).
Sirna against mitf and non targeting control sirna
Manufactured by Horizon Discovery
The SiRNA against MITF and non-targeting control siRNA are laboratory tools used to modulate gene expression. The siRNA against MITF targets the MITF (Microphthalmia-Associated Transcription Factor) gene, while the non-targeting control siRNA does not target any specific gene. These products are designed for research purposes only and their core function is to facilitate the study of gene function and regulation.
Automatically generated - may contain errors
Lab products found in correlation
Doxycycline, by Takara Bio (2 mentions)
Plx4720, by Selleck Chemicals (2 mentions)
Alamarblue cell viability reagent, by Thermo Fisher Scientific (2 mentions)
Human phospho rtk array kit, by R&D Systems (2 mentions)
α tubulin, by Cell Signaling Technology (2 mentions)
P rtk, by R&D Systems (2 mentions)
Hb egf, by R&D Systems (2 mentions)
Azd6244, by Selleck Chemicals (2 mentions)
Celltiter glo cell viability assay, by Promega (2 mentions)
U0126, by Selleck Chemicals (2 mentions)
Vemurafenib, by Selleck Chemicals (2 mentions)
P akt, by Cell Signaling Technology (2 mentions)
Gapdh, by Cell Signaling Technology (2 mentions)
Epidermal growth factor (egf), by R&D Systems (2 mentions)
P erk, by Cell Signaling Technology (2 mentions)
2 protocols using sirna against mitf and non targeting control sirna
1
Investigating MAPK and AKT Signaling
2
Investigating MAPK and AKT Signaling
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!